What will be the cost of Keir Starmer's new medicines deal with Donald Trump? British lives | Aditya Chakrabortty
Briefly

What will be the cost of Keir Starmer's new medicines deal with Donald Trump? British lives | Aditya Chakrabortty
"A world-beating deal, boasts the science minister, Patrick Vallance. It paves the way for the UK to become a global hub for life sciences, claims the business secretary, Peter Kyle, with the government press release adding: Tens of thousands of NHS patients will benefit. Presented with such triumph, His Majesty's press is up on its hindlegs. Happy pills ran a laudatory editorial in the Times, while the Daily Mail sportingly thanked Donald Trump for his US lifeline for UK pharma. Britain 1, America 0!"
"A major win for American workers, says the trade secretary, Howard Luttnick, which ensures that the breakthroughs of tomorrow will be built, tested, and produced on American soil. The health secretary, Robert F Kennedy Jr, acclaims results that put Americans first. One deal, two diametrically opposed readings: who is right? The answer, I regret to inform you, is the Trumpettes. Take this headline from the liberals at the New York Times: To avoid tariffs, UK agrees to Trump's demand to pay more for drugs."
The governments of Donald Trump and Keir Starmer struck a medicines agreement with major financial and political consequences. UK ministers hailed the deal as a world-beating opportunity to make the UK a global life-sciences hub and promised NHS patient benefits. US officials presented the pact as a win for American workers that secures domestic production and prioritizes Americans. Media reactions diverged sharply, with British outlets celebrating and American outlets warning that the UK agreed to pay more to avoid tariffs. Independent modelling and pre-signing estimates indicate the arrangement will increase costs and may lead to reduced access to treatments and loss of British lives.
Read at www.theguardian.com
Unable to calculate read time
[
|
]